research Telogen Effluvium Following the Treatment of Euglycemic Diabetic Ketoacidosis in a Patient With Heavy Soft Drink Intake: A Case Report
This case report explores a 28-year-old man with type 2 diabetes who experienced telogen effluvium, a type of hair loss, following treatment for euglycemic diabetic ketoacidosis with luseogliflozin, possibly triggered by physical stress related to his condition and treatment.